Related Experiment Video
Updated: Jan 25, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Transplant Energize Me Patient Outcome (TEMPO): A Quality Improvement Project that Maintains Functional Mobility in
Anne Gonzales1, Erin Gates1, Nabanita Bhunia2
1Clinical Therapy Services, Nationwide Children's Hospital, Columbus, Ohio.
Insights
The Transplant Energize Me Patient Outcome (TEMPO) project successfully maintained physical function and strength in pediatric patients undergoing allogeneic hematopoietic cell transplantation (HCT). This quality improvement initiative showed sustained benefits at 100 days post-transplant without increasing resource use.
Area of Science:
- Pediatric Hematology
- Transplantation Medicine
- Rehabilitation Science
Background:
- Allogeneic hematopoietic cell transplantation (HCT) is a curative treatment for pediatric hematologic diseases.
- HCT leads to significant physical deconditioning, impacting daily function and increasing health risks.
- Maintaining physical function during HCT is crucial for patient recovery and long-term outcomes.
Purpose of the Study:
- To implement and evaluate the Transplant Energize Me Patient Outcome (TEMPO) project, a quality improvement initiative.
- To maintain physical functional mobility and strength in pediatric allogeneic HCT patients throughout hospitalization.
- To assess the impact of TEMPO on resource utilization and compare it with historical controls.
Main Methods:
- The TEMPO project incorporated individualized, developmentally appropriate exercises managed by a multidisciplinary team.
- Objective physical stamina metrics were recorded at admission, weekly, at discharge, and 100 days post-graft infusion (D100).
- Resource utilization (length of stay, parenteral feeds, narcotics, readmissions, infections) was compared between TEMPO and pre-TEMPO cohorts.
Main Results:
- TEMPO participation preserved physical endurance and functional strength during hospitalization.
- These improvements in physical function were significantly sustained or enhanced at D100.
- No significant differences in resource utilization were observed between the TEMPO and historical control groups.
Conclusions:
- The TEMPO quality improvement project effectively maintains physical functional mobility, strength, and endurance in pediatric allogeneic HCT patients.
- The observed benefits in physical function are objectively sustained at 100 days post-transplant.
- TEMPO demonstrates a successful strategy to mitigate deconditioning associated with HCT in pediatric populations.
Abstract:
Allogeneic hematopoietic cell transplantation (HCT) remains the definite cure for many pediatric hematologic diseases but causes profound deconditioning, which impairs daily physical functioning and may lead to further health complications. The Transplant Energize Me Patient Outcome (TEMPO) project is a standard-of-care, quality improvement (QI) project whose primary objective is to maintain physical functional mobility and strength throughout admission for pediatric allogeneic HCT patients. Specifically, TEMPO incorporates individualized and developmentally appropriate exercises and activities that are administered by a multidisciplinary team, who objectively measure and record a patient's physical stamina at predetermined frequencies. Discipline-specific metrics at admission, at weekly intervals, at discharge, and at 100 days after graft infusion (D100) are recorded in templated flowsheets in the electronic medical record. As a secondary objective, resource utilization as measured by length of stay, duration of parenteral feeds and narcotics, readmission by D100, and infections was compared between TEMPO and historical control (pre-TEMPO) allogeneic HCT patients. TEMPO participation maintained physical endurance and functional strength throughout hospitalization, an effect that was significantly sustained or improved at D100. Resource utilization did not significantly differ between patient cohorts. Taken together, the TEMPO QI Project maintains physical functional mobility, strength, and endurance, thereby decreasing physical deconditioning in pediatric allogeneic HCT patients, an effect that is objectively sustained at D100.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction

